A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.
about
Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetesDiabetes mellitus: The epidemic of the century.Current knowledge of Japanese type 1 diabetic syndrome.Human pancreatic exocrine response to nutrients in health and disease.Fulminant type 1 diabetes--an important subtype in East Asia.Pancreatic pathology in type 1 diabetes mellitus.Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray.Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma.Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case seriesPathogenesis of fulminant type 1 diabetes.Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes.CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.
P2860
Q33383716-D2047475-8A7E-48DA-89AD-076360F5665EQ34671155-62BA5450-0764-429C-B076-0DED9073431FQ34979242-8D52E552-6404-4E8C-B6A5-BD850E9E89DBQ35790597-903D39FF-E3BF-4909-B248-59FBCA48D641Q37954240-207CAF58-303E-4D72-B072-402B4FCB837FQ38187570-4DB0734B-8D12-4BEB-A5EF-F85BCB11C617Q38365047-392D9A3D-4CB5-4189-BC82-364989B85689Q39402183-24187434-85BE-45CC-913D-97193B7D31F2Q42126510-3CFFAF10-BD82-4354-9298-9D814D825C86Q42913827-3A4236DC-1733-4DBA-AA8D-2173EBE5F832Q46592485-C0D9B6EF-F7DD-4A83-8962-B9FDCE077DECQ47223640-360AACF3-7EF1-4E7C-B39A-A2E6C46D1DA3Q51052498-22579CEE-F448-4043-BBDF-5DD275CE2463
P2860
A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A proposal of three distinct s ...... cal and pathological evidence.
@ast
A proposal of three distinct s ...... cal and pathological evidence.
@en
A proposal of three distinct s ...... cal and pathological evidence.
@nl
type
label
A proposal of three distinct s ...... cal and pathological evidence.
@ast
A proposal of three distinct s ...... cal and pathological evidence.
@en
A proposal of three distinct s ...... cal and pathological evidence.
@nl
prefLabel
A proposal of three distinct s ...... cal and pathological evidence.
@ast
A proposal of three distinct s ...... cal and pathological evidence.
@en
A proposal of three distinct s ...... cal and pathological evidence.
@nl
P2093
P2860
P1433
P1476
A proposal of three distinct s ...... cal and pathological evidence.
@en
P2093
Hanafusa T
Matsuzawa Y
Miyagawa J
P2860
P304
P356
10.3109/07853890008998833
P407
P577
2000-11-01T00:00:00Z